Advancing Novel Classes of AntibioticsRoche’s commitment to creating and developing researching and developing new medicines to tackle drug resistance
Roche’s lifesaving legacy in antibiotic innovationFinding new ways to kill bacteria is crucial against antimicrobial resistance. For Roche, it's been a 45-year legacy of innovative antibiotics and saving lives.
An immune upgrade for organoidsEngineering breakthrough for intestinal epithelial organoids with tissue-resident immune cells recapitulate drug-induced, immune-mediated toxicities.
Improving the patient journeyFrom diagnostics to therapeutics, Roche is innovating new options for people living with Alzheimer’s disease
Engineering models of the human gutNew “organoid-on-a-chip” system merges stem cell biology and innovation in engineering to better represent organs for research and development.
Doubling our visionBy combining a unique medical device with new medicines, Roche is turning breakthrough discoveries into groundbreaking inventions for patients with retinal disease
Redefining Parkinson’s diseaseRedefining Parkinson's Disease: Science, technology, and passion converge to revolutionise the understanding and treatment of neurodegenerative diseases, offering new hope for patients and families.
Defining hallmarks of stem cellsA new review from Roche scientists describe stem cells’ unique and shared features, laying the foundation of what is known about them and mapping new approaches in drug discovery
New era of antibiotics potentially in sight after more than 50 yearsBy finding a new class of antibiotics, Roche’s scientists could contribute to reducing the globally growing number of deaths related to hospital-acquired bacterial infections
The RNA Hub - An integrated multidisciplinary research communityRoche is shaking up the drug development process for new RNA-based medicines
Fighting inflammation in the eyeHow a potential new molecule for retinal diseases could help close a gap of unmet medical need
An innovative hub for innovative medicinesRoche is shaking up the drug development process for new RNA-based medicines
From idea, to molecule, to medicineThe step-by-step evolution of a potential new approach to treating cancer.
Modeling the futureRoche launches the Institute of Human Biology to pioneer new approaches for drug discovery and development, leveraging human model systems such as organoids
Looking beyond the horizon to change the trajectory for vision lossWith millions of people worldwide living with retinal conditions, scientists at Roche have the ultimate goal to hopefully prevent, and even reverse, vision loss.
Meet the antibody engineersHow teams across Roche are tweaking versatile immune tools to develop new treatments
Harnessing Immune Power Against TumoursHow Roche follows the science to continue improving on bold new therapeutic strategies.
Pushing the boundaries of science: Following the FibroblastsHow describing the structural cells of tissues sheds new light on autoimmune disease
Reaching new antibody heightsHear reflections from Roche pRED scientists on the science and innovation behind the pioneering advances in antibody technology for novel antibody therapeutics.